{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:45:41Z","timestamp":1790815541414,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":2052,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005390","name":"Alfred \u00d6sterlunds Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ajpath.2014.01.019","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T08:00:45Z","timestamp":1395043245000},"page":"1518-1528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Bortezomib Partially Improves Laminin \u03b12 Chain\u2013Deficient Muscular Dystrophy"],"prefix":"10.1016","volume":"184","author":[{"given":"Zandra","family":"K\u00f6rner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cibely C.","family":"Fontes-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Carmignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Durbeej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2014.01.019_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.ejhg.5200743","article-title":"Merosin-deficient muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for \u03b12 chain of laminin)","volume":"10","author":"Allamand","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ajpath.2014.01.019_bib2","first-page":"1203","article-title":"The congenital muscular dystrophies","volume":"vol 2","author":"Voit","year":"2004"},{"key":"10.1016\/j.ajpath.2014.01.019_bib3","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1073\/pnas.85.5.1544","article-title":"Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development","volume":"85","author":"Leivo","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2014.01.019_bib4","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1073\/pnas.91.12.5572","article-title":"Defective muscle basement membrane and lack of M-laminin in the dystrophic dy\/dy mouse","volume":"91","author":"Xu","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2014.01.019_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng1095-216","article-title":"Mutations in the laminin \u03b12 chain gene (LAMA2) cause merosin-deficient muscular dystrophy","volume":"11","author":"Helbling-Leclerc","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2014.01.019_bib6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/355696a0","article-title":"Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix","volume":"355","author":"Ibraghimov-Beskrovnaya","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2014.01.019_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/emboj\/18.4.863","article-title":"Binding of the G domains of laminin \u03b11 and \u03b12 chains and perlecan to heparin, sulfatides, \u03b1-dystroglycan and several extracellular matrix proteins","volume":"18","author":"Talts","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2014.01.019_bib8","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1074\/jbc.M102188200","article-title":"Alternative splice variants of \u03b17\u03b21 integrin selectively recognize different laminin isoforms","volume":"277","author":"von der Mark","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2014.01.019_bib9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib10","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2014.01.019_bib11","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1172\/JCI119716","article-title":"Integrins (\u03b17\u03b21) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy","volume":"10","author":"Vachon","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2014.01.019_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35095054","article-title":"An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy","volume":"413","author":"Moll","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2014.01.019_bib13","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.febslet.2006.02.027","article-title":"Laminin \u03b11 chain mediated reduction of laminin \u03b12 chain deficient muscular dystrophy involves integrin \u03b17\u03b21 and dystroglycan","volume":"580","author":"Gawlik","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ajpath.2014.01.019_bib14","first-page":"1601","article-title":"Activation of the Lama2 gene in muscle regeneration: abortive regeneration in laminin \u03b12-deficiency","volume":"79","author":"Kuang","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2014.01.019_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0960-8966(00)00203-0","article-title":"Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy","volume":"11","author":"Hayashi","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2014.01.019_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2044-5040-1-9","article-title":"Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies","volume":"1","author":"Gawlik","year":"2011","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.ajpath.2014.01.019_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-5793(97)01007-7","article-title":"Laminin \u03b12 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy","volume":"415","author":"Miyagoe","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ajpath.2014.01.019_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/s0960-8966(02)00266-3","article-title":"Laminin \u03b12 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice","volume":"3","author":"Guo","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2014.01.019_bib19","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/hmg\/ddh190","article-title":"Laminin \u03b11 chain reduces muscular dystrophy in laminin \u03b12 chain deficient mice","volume":"13","author":"Gawlik","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2014.01.019_bib20","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/hmg\/ddl201","article-title":"Laminin \u03b11 chain improves laminin \u03b12 chain deficient neuropathy","volume":"15","author":"Gawlik","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2014.01.019_bib21","doi-asserted-by":"crossref","first-page":"e11549","DOI":"10.1371\/journal.pone.0011549","article-title":"Distinct roles for laminin globular domains in laminin \u03b11 chain mediated rescue of murine laminin \u03b12 chain deficiency","volume":"5","author":"Gawlik","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2014.01.019_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/mus.21616","article-title":"Transgenic overexpression of laminin \u03b11 chain in laminin \u03b12 chain-deficient mice rescues the disease throughout the lifespan","volume":"42","author":"Gawlik","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2014.01.019_bib23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1172\/JCI3705","article-title":"Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models [Erratum appeared in J Clin Invest 1998, 102(6):following 1275]","volume":"102","author":"Kuang","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2014.01.019_bib24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1096\/fj.04-3376com","article-title":"Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-\u03b12-deficient mice","volume":"19","author":"Bentzinger","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2014.01.019_bib25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1083\/jcb.200611152","article-title":"Linker molecules between laminins and dystroglycan ameliorate laminin-\u03b12-deficient muscular dystrophy at all disease stages","volume":"176","author":"Meinen","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib26","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1242\/jcs.083311","article-title":"Transgenic overexpression of the \u03b17 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A","volume":"124","author":"Doe","year":"2011","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ajpath.2014.01.019_bib27","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI22928","article-title":"Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy","volume":"114","author":"Girgenrath","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2014.01.019_bib28","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/hmg\/ddr126","article-title":"Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A","volume":"20","author":"Kumar","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2014.01.019_bib29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.109.160754","article-title":"Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-\u03b12 deficiency","volume":"331","author":"Erb","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajpath.2014.01.019_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.21523","article-title":"Pathology is alleviated by doxycycline in a laminin-\u03b12-null model of congenital muscular dystrophy","volume":"65","author":"Girgenrath","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22694","article-title":"Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy2J\/dy2J mouse","volume":"71","author":"Elbaz","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2044-5040-2-18","article-title":"Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-\u03b12-deficient congenital muscular dystrophy (MDC1A)","volume":"2","author":"Meinen","year":"2012","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.ajpath.2014.01.019_bib33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ajpath.2011.12.019","article-title":"Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy","volume":"180","author":"Rooney","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/hmg\/ddq499","article-title":"Proteasome inhibition improves the muscle of laminin \u03b12 chain-deficient mice","volume":"20","author":"Carmignac","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2014.01.019_bib35","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1093\/hmg\/ddr427","article-title":"Autophagy is increased in laminin \u03b12 chain-deficient muscle and inhibition improves muscle morphology in a mouse model of MDC1A","volume":"20","author":"Carmignac","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2014.01.019_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1083\/jcb.201210077","article-title":"Development of proteasome inhibitors as research tools and cancer drugs","volume":"199","author":"Goldberg","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib37","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.2174\/1381612811319220012","article-title":"From bortezomib to other inhibitors of the proteasome and beyond","volume":"19","author":"Buac","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajpath.2014.01.019_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1097-2765(00)80410-4","article-title":"Disruption of the \u03b2-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E","volume":"5","author":"Durbeej","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2014.01.019_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jgm.1140","article-title":"Drug-induced readthrough of premature stop codons leads to the stabilization of laminin \u03b12 chain mRNA in CMD myotubes","volume":"10","author":"Allamand","year":"2008","journal-title":"J Gene Med"},{"key":"10.1016\/j.ajpath.2014.01.019_bib40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2007.11.001","article-title":"FoxO3 controls autophagy in skeletal muscle in\u00a0vivo","volume":"6","author":"Mammucari","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2014.01.019_bib41","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1111\/j.1742-4658.2010.07820.x","article-title":"A new pathway encompassing calpain 3 and its newly identified substrate cardiac ankyrin repeat protein is involved in the regulation of the nuclear factor \u03baB pathway in skeletal muscle","volume":"277","author":"Laure","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.ajpath.2014.01.019_bib42","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.bbagen.2012.11.009","article-title":"Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?","volume":"1830","author":"Fontes-Oliveira","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2014.01.019_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib44","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2014.01.019_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ng1194-297","article-title":"Murine muscular dystrophy caused by a mutation in the laminin \u03b12 (Lama2) gene","volume":"8","author":"Xu","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2014.01.019_bib46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/hmg\/4.6.1055","article-title":"Identification of a novel mutant transcript of laminin \u03b12 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice","volume":"4","author":"Sunada","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2014.01.019_bib47","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2353\/ajpath.2009.090052","article-title":"Myotendinous junction defects and reduced force transmission in mice that lack \u03b17 integrin and utrophin","volume":"175","author":"Welser","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib48","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2353\/ajpath.2010.090468","article-title":"Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies","volume":"176","author":"Gazzerro","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bbrc.2005.12.224","article-title":"Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin \u03b12 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?","volume":"342","author":"Taniguchi","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2014.01.019_bib50","doi-asserted-by":"crossref","first-page":"e80263","DOI":"10.1371\/journal.pone.0080263","article-title":"Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular dystrophy","volume":"8","author":"Zaharieva","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2014.01.019_bib51","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1038\/mtna.2012.26","article-title":"Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy","volume":"1","author":"Roberts","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ajpath.2014.01.019_bib52","doi-asserted-by":"crossref","first-page":"E693","DOI":"10.1152\/ajpendo.00281.2004","article-title":"USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states","volume":"288","author":"Combaret","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2014.01.019_bib53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/emmm.201100151","article-title":"Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice","volume":"3","author":"Meinen","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajpath.2014.01.019_bib54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.leu.2402417","article-title":"The proteasome: a novel target for cancer chemotherapy","volume":"16","author":"Almond","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2014.01.019_bib55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1548-5315(11)70481-8","article-title":"Managing and avoiding bortezomib toxicity","volume":"4","author":"Menashe","year":"2007","journal-title":"Community Oncol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib56","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2012-10-459883","article-title":"Carfilzomib","volume":"121","author":"Kortuem","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2014.01.019_bib57","doi-asserted-by":"crossref","first-page":"e61367","DOI":"10.1371\/journal.pone.0061367","article-title":"Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs","volume":"8","author":"Araujo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2014.01.019_bib58","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajpath.2013.11.017","article-title":"Loss of dystrophin and \u03b2-sarcoglycan significantly exacerbates the phenotype of laminin \u03b12 chain-deficient animals","volume":"184","author":"Gawlik","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1172\/JCI30556","article-title":"Interplay of IKK\/NF-\u03baB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy","volume":"117","author":"Acharyya","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2014.01.019_bib60","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0002-9440(10)63523-7","article-title":"Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins","volume":"163","author":"Bonuccelli","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib61","doi-asserted-by":"crossref","first-page":"C577","DOI":"10.1152\/ajpcell.00434.2005","article-title":"Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment","volume":"290","author":"Assereto","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ajpath.2014.01.019_bib62","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.4161\/cc.6.10.4182","article-title":"Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice","volume":"6","author":"Bonuccelli","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ajpath.2014.01.019_bib63","article-title":"A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice","volume":"4","author":"Selzby","year":"2012","journal-title":"PLoS Curr"},{"key":"10.1016\/j.ajpath.2014.01.019_bib64","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1074\/jbc.M111.329078","article-title":"Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells","volume":"287","author":"Azakir","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2014.01.019_bib65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4161\/auto.5905","article-title":"Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle","volume":"4","author":"Mammucari","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.ajpath.2014.01.019_bib66","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mus.10258","article-title":"Inhibition of dystroglycan binding to laminin disrupts the PI3K\/AKT pathway and survival signaling in muscle","volume":"26","author":"Langenbach","year":"2002","journal-title":"Muscle Nerve"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014000935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014000935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:03:36Z","timestamp":1762081416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944014000935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0002944014000935"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.01.019","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bortezomib Partially Improves Laminin \u03b12 Chain\u2013Deficient Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}